-
Je něco špatně v tomto záznamu ?
Direct administration of rutin does not protect against catecholamine cardiotoxicity
P. Mladenka, L. Zatloukalova, T. Simunek, Z. Bobrovova, V. Semecky, P. Nachtigal, P. Haskova, E. Mackova, J. Vavrova, M. Holeckova, V. Palicka, R. Hrdina
Jazyk angličtina Země Irsko
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- agonisté adrenergních beta-receptorů farmakologie MeSH
- cévní rezistence účinky léků MeSH
- chelátory farmakologie MeSH
- financování organizované MeSH
- funkční vyšetření srdce MeSH
- glutathion metabolismus MeSH
- interpretace statistických dat MeSH
- isoprenalin farmakologie MeSH
- kardiomyocyty metabolismus patologie účinky léků MeSH
- katecholaminy antagonisté a inhibitory toxicita MeSH
- krysa rodu rattus MeSH
- minutový srdeční výdej účinky léků MeSH
- myokard patologie MeSH
- nemoci srdce chemicky indukované patologie prevence a kontrola MeSH
- potkani Wistar MeSH
- reaktivní formy kyslíku metabolismus MeSH
- rutin farmakologie MeSH
- scavengery volných radikálů metabolismus MeSH
- velikost orgánu účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
High levels of catecholamines are cardiotoxic and may trigger acute myocardial infarction (AMI). Similarly, the synthetic catecholamine isoprenaline (ISO) evokes a pathological state similar to AMI. During AMI there is a marked increase of free iron and copper which are crucial catalysts of reactive oxygen species formation. Rutin, a natural flavonoid glycoside possessing free radical scavenging and iron/copper chelating activity, may therefore be potentially useful in reduction of catecholamine cardiotoxicity as was previously demonstrated after its long-term peroral administration. Male Wistar:Han rats received rutin (46 or 11.5 mg kg(-1) i.v.) alone or with necrogenic dose of ISO (100 mg kg(-1) s.c.). Haemodynamic parameters were measured 24h after drug application together with analysis of blood, myocardial content of elements and histological examination. Results were confirmed by cytotoxicity studies using cardiomyoblast cell line H9c2. Rutin in a dose of 46 mg kg(-1) aggravated ISO-cardiotoxicity while the dose of 11 mg kg(-1) had no effect. These unexpected results were in agreement with in vitro experiments, where co-incubation with larger concentrations of rutin significantly augmented ISO cytotoxicity. Our results, in contrast to previous studies in the literature, suggest that the reported positive effects of peroral administration of rutin were unlikely to have been mediated by rutin per se but probably by its metabolite(s) or by some other, at this moment, unknown adaptive mechanism(s), which merit further investigation.
- 000
- 04007naa 2200637 a 4500
- 001
- bmc11006150
- 003
- CZ-PrNML
- 005
- 20120726115403.0
- 008
- 110331s2009 ie e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Mladěnka, Přemysl. $7 xx0233006
- 245 10
- $a Direct administration of rutin does not protect against catecholamine cardiotoxicity / $c P. Mladenka, L. Zatloukalova, T. Simunek, Z. Bobrovova, V. Semecky, P. Nachtigal, P. Haskova, E. Mackova, J. Vavrova, M. Holeckova, V. Palicka, R. Hrdina
- 314 __
- $a Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Department of Pharmacology and Toxicology, Czech Republic.
- 520 9_
- $a High levels of catecholamines are cardiotoxic and may trigger acute myocardial infarction (AMI). Similarly, the synthetic catecholamine isoprenaline (ISO) evokes a pathological state similar to AMI. During AMI there is a marked increase of free iron and copper which are crucial catalysts of reactive oxygen species formation. Rutin, a natural flavonoid glycoside possessing free radical scavenging and iron/copper chelating activity, may therefore be potentially useful in reduction of catecholamine cardiotoxicity as was previously demonstrated after its long-term peroral administration. Male Wistar:Han rats received rutin (46 or 11.5 mg kg(-1) i.v.) alone or with necrogenic dose of ISO (100 mg kg(-1) s.c.). Haemodynamic parameters were measured 24h after drug application together with analysis of blood, myocardial content of elements and histological examination. Results were confirmed by cytotoxicity studies using cardiomyoblast cell line H9c2. Rutin in a dose of 46 mg kg(-1) aggravated ISO-cardiotoxicity while the dose of 11 mg kg(-1) had no effect. These unexpected results were in agreement with in vitro experiments, where co-incubation with larger concentrations of rutin significantly augmented ISO cytotoxicity. Our results, in contrast to previous studies in the literature, suggest that the reported positive effects of peroral administration of rutin were unlikely to have been mediated by rutin per se but probably by its metabolite(s) or by some other, at this moment, unknown adaptive mechanism(s), which merit further investigation.
- 650 _2
- $a agonisté adrenergních beta-receptorů $x farmakologie $7 D000318
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a minutový srdeční výdej $x účinky léků $7 D002302
- 650 _2
- $a katecholaminy $x antagonisté a inhibitory $x toxicita $7 D002395
- 650 _2
- $a chelátory $x farmakologie $7 D002614
- 650 _2
- $a interpretace statistických dat $7 D003627
- 650 _2
- $a scavengery volných radikálů $x metabolismus $7 D016166
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a nemoci srdce $x chemicky indukované $x patologie $x prevence a kontrola $7 D006331
- 650 _2
- $a funkční vyšetření srdce $7 D006334
- 650 _2
- $a isoprenalin $x farmakologie $7 D007545
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myokard $x patologie $7 D009206
- 650 _2
- $a kardiomyocyty $x metabolismus $x patologie $x účinky léků $7 D032383
- 650 _2
- $a velikost orgánu $x účinky léků $7 D009929
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a rutin $x farmakologie $7 D012431
- 650 _2
- $a cévní rezistence $x účinky léků $7 D014655
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Zatloukalová, Libuše $7 xx0113003
- 700 1_
- $a Šimůnek, Tomáš $7 xx0019029
- 700 1_
- $a Bobrovová, Zuzana $7 xx0106425
- 700 1_
- $a Semecký, Vladimír, $d 1943- $7 nlk19990073843
- 700 1_
- $a Nachtigal, Petr $7 uk2009304471
- 700 1_
- $a Hašková, Pavlína. $7 xx0267424
- 700 1_
- $a Potůčková, Eliška $7 xx0153394
- 700 1_
- $a Vávrová, Jaroslava, $d 1958- $7 xx0014618
- 700 1_
- $a Holečková, Magdalena $7 xx0074146
- 700 1_
- $a Palička, Vladimír, $d 1946- $7 jn99240000830
- 700 1_
- $a Hrdina, Radomír $7 xx0077249
- 773 0_
- $t Toxicology $w MED00004533 $g Roč. 255, č. 1-2 (2009), s. 25-32 $x 0300-483X
- 910 __
- $a ABA008 $b x $y 2
- 990 __
- $a 20110414100213 $b ABA008
- 991 __
- $a 20120726115442 $b ABA008
- 999 __
- $a ok $b bmc $g 833768 $s 698242
- BAS __
- $a 3
- BMC __
- $a 2009 $b 255 $c 1-2 $d 25-32 $i 0300-483X $m Toxicology $n Toxicology $x MED00004533
- LZP __
- $a 2011-1B09/dkme